Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases

Medical Oncology

Volumn 16, Issue 1, 1999, Pages 58-64

  Huang, Xiao Jun ^a,c   Wiernik, Peter H ^a   Klein, Robert S ^a   Gallagher, Robert E ^a,b  

^a ALBERT EINSTEIN CANCER CENTER   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Acute promyelocytic leukemia; Arsenoxide; Caspase inhibitor; HL 60; NB4; PARP; PKC; Programmed cell death

Indexed keywords

ARSENIC TRIOXIDE; CASPASE; ETOPOSIDE; PROTEIN KINASE C; PROTEINASE INHIBITOR;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL STRUCTURE; DRUG MECHANISM; ELECTROPHORETIC MOBILITY; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INCUBATION TIME; LEUKEMIA CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033044472     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02787360     Document Type: Article

References (22)

1. 3 induces NB4 cell apoptosis with downregulation of bcl-2 expression and alteration of PML-RARα/PML protein localization. Blood 1996; 88: 1052-1061.
2. 3 exerts dose-dependent dual effects on APL cells. Blood 1998; 89: 3345-3353.
3. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997; 89: 3354-3360.
4. 3) in acute promyelocytic leukemia. Proc Am Soc Clin Oncol 1998; 17: 6a.
5. 3) induced apoptosis by retinoic acid (RA) in RA-sensitive (S) and RA-resistant (R) HL-60 myeloid leukemia cells. Blood 1997; 90 (Suppl. 1): 329a.
6. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-365.
7. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 1997; 91: 443-445.
8. Shimizu T, Pommier Y. Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases. Leukemia 1997; 11: 1238-1244.
9. Martins LM et al. Activation of multiple interleukin-1β converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J Biol Chem 1997; 272: 7421-7430.
10. Martins LM et al. Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood 1998; 90: 4283-4296.
11. Droin N et al. Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis. Oncogene 1998; 16: 2885-2894.
12. Datta R et al. Activation of the CPP32 protease in apoptosis induced by 1-β-D-arabinofuranosylcytosine and other DNA-damaging agents. Blood 1996; 88: 1936-1943.
13. Antoku K, Liu Z, Johnson DE. Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents. Leukemia 1997; 11: 1665-1672.
14. Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995; 375: 78-81.
15. Kaufmann SH et al. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53: 3976-3985.
16. Grant S, Jarvis WD. Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy. Clin Cancer Res 1996; 2: 1915-1920.
17. Mansat V et al. The protein kinase C activators phorbol esters and phosphatidylserine inhibit neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Cancer Res 1997; 57: 5300-5400.
18. Darzynkiewicz Z et al. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 1997; 27: 1-20.
19. Los M et al. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 1995; 375: 81-83.
20. Forbes IJ, Zalewski PD, Giannakis C, Cleveland JL. Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp Cell Res 1992; 198: 367-372.
21. Jarvis WD et al. Effects of bryostatin 1 and other activators of protein kinase C on 1-β-D-arabinofuranosylcytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells. Biochem Pharmacol 1994; 47: 839-852.
22. Solary E, Bertrand R, Kohn KW, Pommier Y. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase inhibitors. Blood 1993; 81: 1353-1368.